Filing Details

Accession Number:
0000899243-23-002483
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-24 18:20:44
Reporting Period:
2023-01-20
Accepted Time:
2023-01-24 18:20:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1640266 Voyager Therapeutics Inc. VYGR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192595 I Robert Tepper 201 Brookline Ave, Suite 1401
Boston MA 02115
No No Yes No
1569705 Third Rock Ventures Iii, L.p. C/O Third Rock Ventures, Llc,
201 Brookline Ave, Suite 1401
Boston MA 02215
No No Yes No
1637299 Trv Gp Iii, Llc 201 Brookline Ave, Suite 1401
Boston MA 02115
No No Yes No
1637300 Third Rock Ventures Gp Iii, L.p. 201 Brookline Ave, Suite 1401
Boston MA 02115
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-20 100,000 $9.15 5,328,933 No 4 S Direct
Common Stock Disposition 2023-01-23 55,000 $9.06 5,273,933 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 36,701 Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
  2. These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual manager of TRV GP III LLC is Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
  4. The shares are directly held by Tepper.